Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lenk

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitroJ Astermark, J Voorberg, H Lenk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2001
Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assayJ Klinge, G Auerswald, U Budde, et al.
Oncology|January 1, 1990
Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patientsH Lenk, S Tanneberger, N Wiener, et al.
Klinische Padiatrie|September 23, 1998
[Clinical aspects and epidemiology of hepatitis C in immunosuppressed children with mostly oncologic diseases]K Rieske, M Domula, U G Liebert, et al.
British Journal of Haematology|September 1, 1992
Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and SwedenM Donnér, A C Kristoffersson, H Lenk, et al.
Archiv Fur Geschwulstforschung|January 1, 1989
[Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects]H Hoffmann, W Gutsche, R Amlacher, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentratesCh von Auer, J Oldenburg, M von Depka, et al.
Thrombosis and Haemostasis|February 12, 1999
Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chainR Laub, M Di Giambattista, P Fondu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in GermanyG Auerswald, M von Depka Prondzinski, B Ehlken, et al.
Seminars in Oncology|April 1, 1992
A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinomaE D Kreuser, R U Hilgenfeld, M Matthias, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitroJ Astermark, J Voorberg, H Lenk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2001
Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assayJ Klinge, G Auerswald, U Budde, et al.
Oncology|January 1, 1990
Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patientsH Lenk, S Tanneberger, N Wiener, et al.
Klinische Padiatrie|September 23, 1998
[Clinical aspects and epidemiology of hepatitis C in immunosuppressed children with mostly oncologic diseases]K Rieske, M Domula, U G Liebert, et al.
British Journal of Haematology|September 1, 1992
Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and SwedenM Donnér, A C Kristoffersson, H Lenk, et al.
Archiv Fur Geschwulstforschung|January 1, 1989
[Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects]H Hoffmann, W Gutsche, R Amlacher, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentratesCh von Auer, J Oldenburg, M von Depka, et al.
Thrombosis and Haemostasis|February 12, 1999
Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chainR Laub, M Di Giambattista, P Fondu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in GermanyG Auerswald, M von Depka Prondzinski, B Ehlken, et al.
Seminars in Oncology|April 1, 1992
A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinomaE D Kreuser, R U Hilgenfeld, M Matthias, et al.
Pageof 7